Owen Adams Catherine

SEC Form 4 insider trading activity

Owen Adams Catherine has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including AGIO, ACAD, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 23, 2026.

On the most recent filing, Owen Adams Catherine is listed as Chief Executive Officer at ACADIA PHARMACEUTICALS INC. Inside the rolling window, Owen Adams Catherine reported no open-market purchases and 1 open-market sale totaling $250K in ACAD.

Companies traded

Other insiders at AGIO

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$250K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
ACAD
Owen Adams Catherine
Sale$250KMar 26SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Owen Adams Catherine made?

Owen Adams Catherine has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including AGIO, ACAD since 2026.

Which companies does Owen Adams Catherine trade?

Owen Adams Catherine has filed SEC Form 4 disclosures for 2 companies, including AGIO, ACAD.

When was Owen Adams Catherine's most recent SEC Form 4 filing?

Owen Adams Catherine's most recent SEC Form 4 filing on Tracefour is dated Jun 23, 2026.

What is Owen Adams Catherine's total buy and sell value in the current window?

Inside the rolling retention window, Owen Adams Catherine bought $0 and sold $250K based on SEC Form 4 filings.

What was Owen Adams Catherine's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 11,641 ACAD shares on 2026-03-25, worth $250K, per SEC Form 4 filings.